Company / Income Tax per Share
Mirum Pharmaceuticals, Inc. Income Tax per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.04
FY2025
5-year range
$0.00 / $0.04
FY2021-FY2025
Trend
+81.7%
vs FY2024
Sector context
#55 of 201
Health Care
What the data says
At $0.04, Mirum Pharmaceuticals, Inc.'s income tax per share ranks #147 of 201 in the Health Care sector. Income Tax per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2018 to $0.04 in FY2025.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of +178.8%.
Increased from $0.03 to $0.04 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +221.1%
- 5-Year CAGR
- +178.8%
- 10-Year CAGR
- -
Sector benchmark
#147 of 201 in Health CareTop 73% of 201This company $0.04 Sector average $1.35
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 81.7% year-over-year.
- Ranks #55 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | +81.7% |
| FY2024 | $0.02 | -17.8% |
| FY2023 | $0.03 | +2116.4% |
| FY2022 | $0.00 | +500.4% |
| FY2021 | $0.00 | -15.2% |
| FY2020 | $0.00 | -87.0% |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026